Subaortic Membranes in Patients With Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations

J Am Heart Assoc. 2020 Oct 20;9(20):e016197. doi: 10.1161/JAHA.120.016197. Epub 2020 Oct 15.

Abstract

Background Patients with hereditary hemorrhagic telangiectasia have liver vascular malformations that can cause high-output cardiac failure (HOCF). Known sequelae include pulmonary hypertension, tricuspid regurgitation, and atrial fibrillation. Methods and Results The objectives of this study were to describe the clinical, echocardiographic, and hemodynamic characteristics and prognosis of hereditary hemorrhagic telangiectasia patients with HOCF who were found to have a subaortic membrane (SAoM). A retrospective observational analysis comparing patients with and without SAoM was performed. Among a cohort of patients with HOCF, 9 were found to have a SAoM in the left ventricular outflow tract by echocardiography (all female, mean age 64.8±4.0 years). The SAoM was discrete and located in the left ventricular outflow tract 1.1±0.1 cm below the aortic annular plane. It caused turbulent flow, mild obstruction (peak velocity 2.8±0.2 m/s, peak gradient 32±4 mm Hg), and no more than mild aortic insufficiency. Patients with SAoM (n=9) had higher cardiac output (12.1±1.3 versus 9.3±0.7 L/min, P=0.04) and mean pulmonary artery pressures (36±3 versus 28±2 mm Hg, P=0.03) compared with those without SAoM (n=19) during right heart catheterization. Genetic analysis revealed activin receptor-like kinase 1 mutations in each of the 8 patients with SAoM who had available test results. The presence of a SAoM was associated with a trend towards higher 5-year mortality during follow-up. Conclusions SAoM with mild obstruction occurs in patients with hereditary hemorrhagic telangiectasia and HOCF. SAoM was associated with features of more advanced HOCF and poor outcomes.

Keywords: echocardiography; hereditary hemorrhagic telangiectasia; high‐output cardiac failure; subaortic membrane.

Publication types

  • Observational Study

MeSH terms

  • Activin Receptors, Type II / genetics
  • Cardiac Output, High* / diagnosis
  • Cardiac Output, High* / etiology
  • Cardiac Output, High* / physiopathology
  • Discrete Subaortic Stenosis* / diagnosis
  • Discrete Subaortic Stenosis* / genetics
  • Discrete Subaortic Stenosis* / physiopathology
  • Echocardiography / methods
  • Female
  • Heart Defects, Congenital* / diagnosis
  • Heart Defects, Congenital* / genetics
  • Heart Defects, Congenital* / physiopathology
  • Heart Failure* / diagnosis
  • Heart Failure* / etiology
  • Heart Failure* / physiopathology
  • Humans
  • Liver* / blood supply
  • Liver* / diagnostic imaging
  • Male
  • Middle Aged
  • Mutation
  • Prognosis
  • Retrospective Studies
  • Survival Analysis
  • Telangiectasia, Hereditary Hemorrhagic* / diagnosis
  • Telangiectasia, Hereditary Hemorrhagic* / epidemiology
  • Telangiectasia, Hereditary Hemorrhagic* / genetics
  • Telangiectasia, Hereditary Hemorrhagic* / physiopathology
  • United States / epidemiology
  • Vascular Malformations / diagnosis
  • Vascular Malformations / physiopathology

Substances

  • ACVRL1 protein, human
  • Activin Receptors, Type II

Supplementary concepts

  • Subaortic Stenosis, Membranous